HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 556.42M
Enterprise Value 350.45M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,000.13
Price/Book (mrq)0.84
Enterprise Value/Revenue 3894.28
Enterprise Value/EBITDA 6-1.90

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-91.30%
S&P500 52-Week Change 313.46%
52 Week High 398.49
52 Week Low 30.00
50-Day Moving Average 310.73
200-Day Moving Average 326.57

Share Statistics

Avg Vol (3 month) 334.81k
Avg Vol (10 day) 319.51k
Shares Outstanding 57.54M
Float 6.82M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct. 15, 2019) 45.18k
Short Ratio (Oct. 15, 2019) 40.34
Short % of Float (Oct. 15, 2019) 4N/A
Short % of Shares Outstanding (Oct. 15, 2019) 40.07%
Shares Short (prior month Sep. 13, 2019) 43.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2201/1
Last Split Date 3Oct. 16, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-47,658.20%

Management Effectiveness

Return on Assets (ttm)-27.04%
Return on Equity (ttm)-56.24%

Income Statement

Revenue (ttm)56.41k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-37.00%
Gross Profit (ttm)-313.13k
EBITDA -26.5M
Net Income Avi to Common (ttm)-33.58M
Diluted EPS (ttm)-4.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.84M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)2.15M
Total Debt/Equity (mrq)3.20
Current Ratio (mrq)3.19
Book Value Per Share (mrq)8.88

Cash Flow Statement

Operating Cash Flow (ttm)-25.53M
Levered Free Cash Flow (ttm)-851.16k